Tools to assess the quality of life in patients with Parkinson’s disease: a systematic review

References

• Yamamoto T, Uchiyama T, Higuchi Y, et al. Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson’s disease after deep brain stimulation. J Neurol Sci. 2017;379:18–21.
   PubMed Web of Science ®Google Scholar
• Dogan VB, Koksal A, Dirican A, et al. Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson’s disease. Neurol Sci. 2015;36:2221–2226.
   Web of Science ®Google Scholar
• Zhang S, Liu D, Ye D, et al. Can music-based movement therapy improve motor dysfunction in patients with Parkinson’s disease? Systematic review and meta-analysis. Neurol Sci. 2017;38:1629–1636.
   Web of Science ®Google Scholar
• Galeoto G, Iori F, De Santis R, et al. The outcome measures for loss of functionality in the activities of daily living of adults after stroke: a systematic review. Top Stroke Rehabil. 2019;26:236–245.
   PubMed Web of Science ®Google Scholar
• Marinus J, Ramaker C, van Hilten JJ, et al. Health related quality of life in Parkinson’s disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry. 2002;72:241–248.
   PubMed Web of Science ®Google Scholar
• Alvarado-Bolaños A, Cervantes-Arriaga A, Rodríguez-Violante M, et al. Impact of neuropsychiatric symptoms on the quality of life of subjects with Parkinson’s disease. J Parkinsons Dis. 2015;5:541–548.
   PubMedGoogle Scholar
• Martinez-Martin P, Jeukens-Visser M, Lyons KE, et al. Health-related quality-of-life scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2011;26:2371–2380.
   Web of Science ®Google Scholar
• Tofani M, Galeoto G, Cazzetta D, et al. Validation of the pediatric evaluation of disability inventory in an Italian population with autism spectrum disorder: a cross-sectional study. Clin Ther. 2019. DOI:10.7417/CT.2019.2176
   Google Scholar
• Romagnoli G, Leone A, Romagnoli G, et al. Occupational Therapy’s efficacy in children with Asperger’s syndrome: a systematic review of randomized controlled trials. Clin Ther. 2019. DOI:10.7417/CT.2019.2164
   Google Scholar
• Belluscio V, Bergamini E, Iosa M, et al. The iFST: an instrumented version of the Fukuda Stepping Test for balance assessment. Gait Posture. 2018;60:203–208.
   PubMed Web of Science ®Google Scholar
• Ioncoli M, Berardi A, Tofani M, et al. Crosscultural validation of the community integration questionnaire-revised in an Italian population. Occup Ther Int. 2020;2020:1–7.
   PubMed Web of Science ®Google Scholar
• Berardi A, Saffioti M, Tofani M, et al. Internal consistency and validity of the Jebsen-Taylor hand function test in an Italian population with hemiparesis. NeuroRehabilitation. 2019;45:331–339.
   PubMed Web of Science ®Google Scholar
• Tofani M, Candeloro C, Sabbadini M, et al. A study validating the Italian version of the Level of Sitting Scale in children with cerebral palsy. Clin Rehabil. 2019;33:1810–1818.
   PubMed Web of Science ®Google Scholar
• Tofani M, Nobilia M, Culicchia G, et al. The Italian version of rheumatoid arthritis pain scale (IT-RAPS): psychometric properties on community and clinical samples. Reumatismo. 2019;71:13–18.
   PubMed Web of Science ®Google Scholar
• Amedoro A, Berardi A, Conte A, et al. The effect of aquatic physical therapy on patients with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2020;41:102022.
   PubMed Web of Science ®Google Scholar
• Tramontano M, Morone G, Curcio A, et al. Maintaining gait stability during dual walking task: effects of age and neurological disorders. Eur J Phys Rehabil Med. 2017. DOI:10.23736/S1973-9087.16.04203-9
   PubMed Web of Science ®Google Scholar
• Tramontano M, Bergamini E, Iosa M, et al. Vestibular rehabilitation training in patients with subacute stroke: a preliminary randomized controlled trial. NeuroRehabilitation. 2018;43:247–254.
   PubMed Web of Science ®Google Scholar
• Castelnuovo G, Giusti EM, Manzoni GM, et al. What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation. Front Neurol. 2018;9. DOI:10.3389/fneur.2018.00310
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Rev Esp Nutr Humana y Diet. 2016. DOI:10.1186/2046-4053-4-1
   Google Scholar
• Higgins J, Green S. Cochrane handbook for systematic reviews of interventions | the cochrane collaboration. Cochrane Collab. 2011.
   Google Scholar
• Chandler J, Churchill R, Lasserson T, et al. Methodological standards for the conduct of new Cochrane intervention reviews. 2013. Available from: http://Editorial-Unit.Cochrane.Org/Sites/Editorial-Unit.Cochrane.Org/Files/Uploads/MECIR_conduct_standards%202.3%2002122013.Pdf
   Google Scholar
• Chandler J, Churchill R, Higgins J, et al. Methodological expectations of cochrane intervention reviews (MECIR). Cochrane Database Syst Rev. 2013.
   Google Scholar
• Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34:645–649.
   PubMed Web of Science ®Google Scholar
• Cuerda MC, Apezetxea A, Carrillo L, et al. Development and validation of a specific questionnaire to assess health-related quality of life in patients with home enteral nutrition: NutriQoL® development. Patient Prefer Adherence. 2016;2289–2296. DOI:10.2147/PPA.S110188
   PubMed Web of Science ®Google Scholar
• Noyes J, Lewin S. Chapter 5: extracting qualitative evidence. Suppl Guid Incl Qual Res Cochrane Syst Rev Int. 2011. DOI:10.2307/893875
   Google Scholar
• Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1171–1179.
   Web of Science ®Google Scholar
• Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27:1159–1170.
   Web of Science ®Google Scholar
• Bello-Haas VD, Klassen L, Sheppard S, et al. Psychometric properties of activity, self-efficacy and quality-of-life measures in individuals with parkinson disease. Physiother Canada. 2011. DOI:10.3138/ptc.2009-08
   Web of Science ®Google Scholar
• Kovács N, Horváth K, Aschermann Z, et al. Independent validation of Parkinson’S disease Sleep Scale 2nd version (PDSS-2). Sleep Biol Rhythms. 2016;14:63–73.
   Web of Science ®Google Scholar
• Karşidağ S, Çinar N, Şahin Ş, et al. Validation and reliability study of the turkish version of the neuroquality of life (Neuro-qol)-stigma scale for neurological disorders. Turkish J Med Sci. 2019. DOI:10.3906/sag-1811-50
   PubMed Web of Science ®Google Scholar
• Chen K, Yang YJ, Liu FT, et al. Evaluation of PDQ-8 and its relationship with PDQ-39 in China: a three-year longitudinal study. Health Qual Life Outcomes. 2017;15. DOI:10.1186/s12955-017-0742-5
   Web of Science ®Google Scholar
• Franchignoni F, Giordano A, Ferriero G. Rasch analysis of the short form 8-item Parkinson’s Disease Questionnaire (PDQ-8). Qual Life Res. 2008;17:541–548.
   PubMed Web of Science ®Google Scholar
• Hagell P, Whalley D, McKenna SP, et al. Health status measurement in Parkinson’s disease: validity of the PDQ-39 and nottingham health profile. Mov Disord. 2003;18:773–783.
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Martinez-Martin P, Vargas AP. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version. Mov Disord. 2007. DOI:10.1002/mds.21216
   Web of Science ®Google Scholar
• Jesus Ribeiro J, Vieira E, Ferreira P, et al.Validation of the Portuguese version of the 39-item Parkinson’s disease questionnaire. Eur J Neurol. 2016. DOI:10.1111/ene.13093
   Web of Science ®Google Scholar
• Martínez-Martín P, Frades Payo B. Quality of life in Parkinson’s disease: validation study of the PDQ-39 Spanish version. The grupo centro for study of movement disorders. J Neurol. 1998;245:S34-S38.
   PubMed Web of Science ®Google Scholar
• Suratos C, Saranza G, Jamora R, et al.Translation of the 39-item Parkinson’s disease questionnaire to Filipino. Mov Disord. 2015. DOI:10.1002/mds.26295
   Web of Science ®Google Scholar
• Bushnell DM, Martin ML. Quality of life and Parkinson’s disease: translation and validation of the US Parkinson’s Disease Questionnaire (PDQ-39). Qual Life Res. 1999;8:345–350.
   PubMed Web of Science ®Google Scholar
• Katsarou Z, Bostantjopoulou S, Peto V, et al. Quality of life in Parkinson’s disease: Greek translation and validation of the Parkinson’s disease questionnaire (PDQ-39). Qual Life Res. 2001;10:159–163.
   PubMed Web of Science ®Google Scholar
• Galeoto G, Colalelli F, Massai P, et al. Quality of life in Parkinson’s disease: Italian validation of the Parkinson’s Disease Questionnaire (PDQ-39-IT). Neurol Sci. 2018;39:1903–1909.
   PubMed Web of Science ®Google Scholar
• Tsang KL, Chi I, Ho SL, et al. Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson’s disease. Mov Disord. 2002;17:1036–1040.
   Web of Science ®Google Scholar
• Ma HI, Hwang WJ, Chen-Sea MJ. Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson’s Disease Questionnaire (PDQ-39). Qual Life Res. 2005;14:565–569.
   PubMed Web of Science ®Google Scholar
• Kwon DY, Kim JW, Il H, et al. Translation and validation of the Korean version of the 39-item Parkinson’s disease questionnaire. J Clin Neurol. 2013;9:26.
   Web of Science ®Google Scholar
• Krikmann Ü, Taba P, Lai T, et al. Validation of an estonian version of the Parkinson’s disease questionnaire (PDQ-39). Health Qual Life Outcomes. 2008;6. DOI:10.1186/1477-7525-6-23
   PubMed Web of Science ®Google Scholar
• Luo N, Tan LCS, Li SC, et al. Validity and reliability of the Chinese (Singapore) version of the Parkinson’s Disease Questionnaire (PDQ-39). Qual Life Res. 2005;14:273–279.
   Web of Science ®Google Scholar
• Tan LCS, Luo N, Nazri M, et al. Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson’s disease patients in Singapore. Park Relat Disord. 2004;10:493–499.
   Web of Science ®Google Scholar
• Luo W, Gui XH, Wang B, et al. Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson’s disease questionnaire (PDQ-39). J Zhejiang Univ Sci B. 2010;11:531–538.
   Web of Science ®Google Scholar
• Morley D, Dummett S, Kelly L, et al. Evaluating the psychometric properties of an e-based version of the 39-item Parkinson’s Disease Questionnaire. Health Qual Life Outcomes. 2015. DOI:10.1186/s12955-014-0193-1
   Web of Science ®Google Scholar
• Marinus J, Visser M, Jenkinson C, et al. Evaluation of the Dutch version of the Parkinson’s Disease Questionnaire 39. Park Relat Disord. 2008;14:24–27.
   PubMed Web of Science ®Google Scholar
• Žiropada L, Stefanova E, Potrebić A, et al. Quality of life in Serbian patients with Parkinson’s disease. Qual Life Res. 2009. DOI:10.1007/s11136-009-9500-4
   PubMedGoogle Scholar
• Martínez-Martín P, Serrano-Dueñas M, Vaca-Baquero V. Psychometric characteristics of the Parkinson’s disease questionnaire (PDQ-39) - Ecuadorian version. Park Relat Disord. 2005;11:297–304.
   PubMed Web of Science ®Google Scholar
• Auquier P, Sapin C, Ziegler M, et al. Validation of the French language version of the Parkinson’s Disease Questionnaire - PDQ-39. Rev Neurol (Paris). 2002 Jan;158(1):41–50.
   PubMed Web of Science ®Google Scholar
• Berger K, Broll S, Winkelmann J, et al. Untersuchung zur reliabilitat der deutschen version des PDQ-39: ein krankheitsspezifischer fragebogen zur erfassung der lebensqualitat von Parkinson-patienten. Aktuelle Neurol. 1999;26:180–184.
   Google Scholar
• Kohmoto J, Ohbu S, Nagaoka M, et al. Validation of the Japanese version of the Parkinson’s Disease Questionnaire. Clin Neurol. 2003.
   Google Scholar
• Peto V, Jenkinson C, Fitzpatrick R, et al. The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res. 1995;4:241–248.
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Fitzpatrick R. Cross-cultural evaluation of the short form 8-item Parkinson’s disease questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain. Park Relat Disord. 2007;13:22–28.
   Web of Science ®Google Scholar
• Huang TT, Hsu HY, Wang BH, et al. Quality of life in Parkinson’s disease patients: validation of the short-form eight-item Parkinson’s disease questionnaire (PDQ-8) in Taiwan. Qual Life Res. 2011;20:499–505.
   PubMed Web of Science ®Google Scholar
• Kahraman T, Genc A, Soke F, et al. Validity and Reliability of the Turkish Version of the 8-Item Parkinson’s Disease Questionnaire. Noro Psikiyatr Ars. 2017. DOI:10.5152/npa.2017.19343
   Google Scholar
• Fereshtehnejad SM, Naderi N, Rahmani A, et al. Psychometric study of the Persian short-form eight-item Parkinson’s disease questionnaire (PDQ-8) to evaluate health related quality of life (HRQoL). Health Qual Life Outcomes. 2014;12:78.
   PubMed Web of Science ®Google Scholar
• Katsarou Z, Bostantjopoulou S, Peto V, et al. Assessing quality of life in Parkinson’s disease: can a short-form questionnaire be useful? Mov Disord. 2004;19:308–312.
   PubMed Web of Science ®Google Scholar
• Soulas T, Storme M, Martínez-Martín P, et al. Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson’s disease having undergone DBS-STN: a validation study. Rev Neurol (Paris). 2016. DOI:10.1016/j.neurol.2015.10.010
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P, Carroza-García E, Frades-Payo B, et al. Atributos psicométricos de la scales for outcomes in Parkinson’s disease-psychosocial (SCOPA-PS): validación en España y revisión. Rev Neurol. 2009. DOI:10.33588/rn.4901.2009014
   Google Scholar
• Fereshtehnejad SM, Farhadi F, Hadizadeh H, et al. Cross-cultural validity, reliability, and psychometric properties of the persian version of the scales for outcomes in parkinson’s disease-psychosocial questionnaire. Neurol Res Int. 2014;2014:1–7.
   PubMedGoogle Scholar
• Virués-Ortega J, Carod-Artal FJ, Serrano-Dueñas M, et al. Cross-cultural validation of the Scales for Outcomes in Parkinson’s Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries. Value Health. 2009;12:385–391.
   PubMed Web of Science ®Google Scholar
• Marinus J, Visser M, Martínez-Martín P, et al. A short psychosocial questionnaire for patients with Parkinson’s disease: the SCOPA-PS. J Clin Epidemiol. 2003;56:61–67.
   PubMed Web of Science ®Google Scholar
• Goebel S, Steinmann E, Leplow B, et al. Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep—German version. Neurol Sci. 2018;39:1225–1230.
   PubMed Web of Science ®Google Scholar
• Sung YH, Kim HJ, Koh SB, et al. Ahn, Validation of the Korean version of the scales for outcomes in Parkinson’s Disease-Sleep. J Korean Med Sci. 2018. DOI:10.3346/jkms.2018.33.e14
   Web of Science ®Google Scholar
• Hagell P, Westergren A, Janelidze S, et al. The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson’s disease and healthy controls. Qual Life Res. 2016;25:2571–2577.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Visser M, Rodriguez-Blazquez C, et al. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson’s disease. Mov Disord. 2008;23:1681–1688.
   Web of Science ®Google Scholar
• Marinus J, Visser M, Van Hilten JJ, et al. Assessment of sleep and sleepiness in parkinson disease. Sleep. 2003;26:1049–1054.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Kohnen R, Högl B, et al. Parkinson’s disease sleep scale-validation of the revised version PDSS-2. Mov Disord. 2011;26:644–652.
   Google Scholar
• Arnaldi D, Cordano C, De Carli F, et al. Parkinson’s Disease Sleep Scale 2: application in an Italian population. Neurol Sci. 2016;37:283–288.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Miyamoto M, Miyamoto T, et al. Nocturnal disturbances and restlessness in Parkinson’s disease: using the Japanese version of the Parkinson’s disease sleep scale-2. J Neurol Sci. 2012. DOI:10.1016/j.jns.2012.03.022
   Web of Science ®Google Scholar
• Brown RG, Dittner A, Findley L, et al. The Parkinson fatigue scale. Park Relat Disord. 2005;11:49–55.
   Web of Science ®Google Scholar
• Ozturk EA, Kocer BG, Umay E, et al. Cross-cultural adaptation and psychometric evaluations of the Turkish version of Parkinson Fatigue Scale. Qual Life Res. 2018;27:2719–2730.
   PubMed Web of Science ®Google Scholar
• Fu R, Cui SS, Du JJ, et al. Validation of the Parkinson Fatigue Scale in Chinese Parkinson’s disease patients. Brain Behav. 2017;7:e00712.
   PubMed Web of Science ®Google Scholar
• Dagklis IE, Tsantaki E, Kazis D, et al. The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson’s disease patients. Neurol Sci. 2019;40:683–690.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Wetmore JB, Arbelo JM, et al. Validation study of the Parkinson’s fatigue scale in advanced Parkinson’s disease. Patient Relat Outcome Meas. 2019;Volume 10:141–152.
   Google Scholar
• Hobson P, Holden A, Meara J. Measuring the impact of Parkinson’s disease with the Parkinson’s disease quality of life questionnaire. Age Ageing. 1999;28:341–346.
   Web of Science ®Google Scholar
• Schulzer M, Mak E, Calne SM. The psychometric properties of the Parkinson’s Impact Scale (PIMS) as a measure of quality of life in Parkinson’s disease. Park Relat Disord. 2003;9:291–294.
   Web of Science ®Google Scholar
• Van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708–715.
   PubMed Web of Science ®Google Scholar
• Margis R, Donis KC, Schönwald SV, et al. WHOQOL-OLD assessment of quality of life in elderly patients with Parkinson’s disease: influence of sleep and depressive symptoms. Rev Bras Psiquiatr. 2010;32:125–131.
   PubMed Web of Science ®Google Scholar
• Nowinski CJ, Siderowf A, Simuni T, et al. Neuro-QoL health-related quality of life measurement system: validation in Parkinson’s disease. Mov Disord. 2016;31:725–733.
   PubMedGoogle Scholar
• Cova I, Di Battista ME, Vanacore N, et al. Validation of the Italian version of the non motor symptoms scale for Parkinson’s disease. Park Relat Disord. 2017;34:38–42.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, et al. Independent validation of the scales for outcomes in Parkinson’s disease-autonomic (SCOPA-AUT). Eur J Neurol. 2010;17:194–201.
   Web of Science ®Google Scholar
• Diniz JG, da Silva AC, Nóbrega AC. Quality of life and swallowing questionnaire for individuals with Parkinson’s disease: development and validation. Int J Lang Commun Disord. 2018;53:864–874.
   PubMed Web of Science ®Google Scholar
• Lohnes CA, Earhart GM. External validation of abbreviated versions of the activities-specific balance confidence scale in Parkinson’s disease. Mov Disord. 2010;25:485–489.
   PubMed Web of Science ®Google Scholar
• Jonasson SB, Nilsson MH, Lexell J. Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease. Health Qual Life Outcomes. 2017. DOI:10.1186/s12955-017-0689-6
   PubMedGoogle Scholar
• Baggio JAO, Curtarelli MB, Rodrigues GR, et al. Validity of the Brazilian version of the freezing of gait questionnaire. Arq Neuropsiquiatr. 2012;70:599–603.
   PubMed Web of Science ®Google Scholar
• Krishnan S, Justus S, Meluveettil R, et al. Validity of montreal cognitive assessment in non-english speaking patients with Parkinson’s disease. Neurol India. 2015;63:63.
   Web of Science ®Google Scholar
• Santangelo G, D’Iorio A, Piscopo F, et al. Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale. Qual Life Res. 2017;26:2533–2540.
   PubMed Web of Science ®Google Scholar